Amid new year drug price hikes, Congress calls on manufacturers to justify costs

In 2018, after President Donald Trump publicly condemned the pharmaceutical industry for skyrocketing prescription drug prices, several of the largest drug manufacturers — including Merck, Novartis, Pfizer and Roche — announced a series of temporary price freezes to their brand-name medications.
While touted as a victory by the Trump administration, industry experts were quick to note that without new drug-pricing policies, drug manufacturers were likely to compensate for the losses with significant increases in 2019 — which is exactly what happened, according to a report

Full Story →